A phase II pilot clinical study of experimental research to evaluate the functional rescue of CFTR protein through proteostasis regulators
Phase of Trial: Phase II
Latest Information Update: 04 Mar 2016
Price : $35 *
At a glance
- Drugs Mercaptamine bitartrate (Primary) ; Epigallocatechin gallate
- Indications Cystic fibrosis
- Focus Pharmacodynamics; Therapeutic Use
- 02 Mar 2016 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 11 Jul 2015 Planned number of patients changed from 10 to 60, according to European Clinical Trials Database record.
- 02 Jul 2014 New trial record